Join us at Bioprocess International in Boston
MIP Discovery will be attending Bioprocess International in Boston from September 19th – 21st. Our CCO, Brian Burke will be discussing the current challenges in recovery, purification and analytics in the cell and gene therapy industry, and introducing a novel technology to rapidly tackle some of these challenges; rationally designed synthetic affinity reagents.
Book a meeting with Brian to learn how animal free synthetic affinity reagents can:
- Enable accurate and economical testing throughout all stages of development and manufacturing.
- Allow for more rapid, cost-effective generation and study of novel viral serotypes.
- Tackle transfection reagent (PEI) detection, quantification, and removal.
- More specific purification of high potency particles with a better safety profile.